Working… Menu

Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03704714
Recruitment Status : Recruiting
First Posted : October 15, 2018
Last Update Posted : December 4, 2018
Bristol-Myers Squibb (BMS)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Northwestern University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 11, 2021
Estimated Study Completion Date : June 11, 2022